Stage 2 Innovations
Country not established
- Devices
- 1
What Stage 2 Innovations makes
Stage 2 Innovations manufactures the Renew NCP-5 External Counterpulsation System, a device designed for non-invasive cardiac support by increasing blood flow during diastole through synchronized cuff inflation and deflation around the legs.
The company’s portfolio is regulated under FDA Class II devices and requires 510(k) clearance. The system is listed in the FDA’s 510(k) database. The manufacturer is based in the United States.
Catalogue
Renew NCP-5 External Counterpulsation System Ref K152115
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Stage 2 Innovations have in the registry?
The registry currently lists 1 device for Stage 2 Innovations. Devices recorded under merged duplicate company entries are counted once.
Which registries list Stage 2 Innovations's devices?
Among its 1 most recently registered device, Stage 2 Innovations has devices listed in FDA 510(k) (1 device).
What risk classes do Stage 2 Innovations's devices fall under?
Among its 1 most recently registered device, the classes recorded for Stage 2 Innovations's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Stage 2 Innovations in the registry?
The most recently registered devices listed for Stage 2 Innovations include Renew NCP-5 External Counterpulsation System.